Medical Communications

There’s a whole lot of explaining to do before many U.S. patients and doctors will feel comfortable with biosimilars in …

Amgen has filed a lawsuit in a Californian state court against Coherus Biosciences, suggesting that Coherus had stolen trade secrets. …

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …

Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …

NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …

The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …

Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …